null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

MK-4830 Biosimialr Biosimilar (Anti-LILRB2) Antibody (HDBS0120)

SKU HDBS0120
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein LILRB2
Reactivity Human
Host Species Chimeric Humanized
Isotype IgG4
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

MK-4830 (Anti-LILRB2) Biosimilar Antibody (HDBS0120)

The MK-4830 Biosimilar Anti-LILRB2 Antibody is a cutting-edge tool for researchers delving into the complex world of immune regulation. LILRB2, also known as immune inhibitory receptor, is a key player in modulating immune responses, making it a promising target for studying diseases like cancer, autoimmune disorders, and chronic inflammation.This monoclonal antibody, meticulously produced to target the LILRB2 protein, offers unparalleled specificity and sensitivity for detecting and analyzing LILRB2 in various cell types. Validated for use in Western blot applications, this antibody opens doors for researchers in immunology and cancer research to delve deeper into the intricate mechanisms of immune regulation and its implications for disease development and treatment strategies.

By unlocking the mysteries surrounding LILRB2, researchers can gain invaluable insights into immune homeostasis, inflammation regulation, and allergic reactions. This antibody serves as a powerful tool for unraveling the complexities of immune function and paving the way for innovative therapeutic approaches that modulate immune responses for improved patient outcomes.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose